ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,044.71
-0.04%
Dow Jones
44,697.96
-0.19%
US Dollar vs MXN
20.35587
-0.28%
Brent Oil
73.715
2.54%
Bitcoin
95,523.27
-0.35%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE

  6. Biogen Inc (0R1B) Cotización

Biogen Inc

Biogen Inc (0R1B)

LSE
277.67
0.00
(0.00%)
Cerrado 03 Diciembre 10:30AM
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
277.67
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
5,392
0.00 Rango del Día 0.00
277.67 Rango de 52 semanas 277.67
Capitalización de Mercado [m]
40.234B
Precio Anterior
277.67
Precio de Apertura
-
Hora
2
@
162.13
(O)
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
4,829
Acciones en circulación
144,898,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
20.24
Beneficio por acción (BPA)
8.01
turnover
9.84B
Beneficio neto
1.16B

Acerca de Biogen Inc

Sector
Biological Pds,ex Diagnstics
Industria
Biological Pds,ex Diagnstics
Sitio web
www.biogen.com
Sede
Wilmington, Delaware, USA
Fundado
-
Biogen Inc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker 0R1B. The last closing price for Biogen was US$277.67. Over the last year, Biogen shares have traded in a share price range of US$ 277.67 to US$ 277.67.

Biogen currently has 144,898,000 shares in issue. The market capitalisation of Biogen is US$40.23 billion. Biogen has a price to earnings ratio (PE ratio) of 20.24.

0R1B Últimas noticias

Más noticias

Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity

Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity Dapirolizumab pegol (DZP) met its...

19 Noviembre 2024
UK Regulatory

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease TOKYO and CAMBRIDGE, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd...

14 Noviembre 2024
UK Regulatory

Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD) Conference

Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD) Conference -New testing method highlights link...

30 Octubre 2024
UK Regulatory

Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases

Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases The collaboration aims to...

29 Octubre 2024
UK Regulatory

Biogen Appoints Daniel Quirk, MD, as Chief Medical Officer

Biogen Appoints Daniel Quirk, MD, as Chief Medical Officer CAMBRIDGE, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has appointed Daniel Quirk, M.D., M.P.H., M.B.A. as...

29 Octubre 2024
UK Regulatory

Michael McDonnell, Executive Vice President and Chief Financial Officer to Retire in February 2025

Michael McDonnell, Executive Vice President and Chief Financial Officer to Retire in February 2025 Robin Kramer, Chief Accounting Officer, to Succeed HimCAMBRIDGE, Mass., Oct. 28, 2024 (GLOBE...

28 Octubre 2024
UK Regulatory

Biogen Presents Positive Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024

Biogen Presents Positive Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024 The detailed study results confirmed interim...

26 Octubre 2024
UK Regulatory

Biogen to Present New Data at the Clinical Trials on Alzheimer's Disease (CTAD) 2024 Annual Conference

Biogen to Present New Data at the Clinical Trials on Alzheimer's Disease (CTAD) 2024 Annual Conference CAMBRIDGE, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB...

24 Octubre 2024
UK Regulatory

Biogen Announces Late Breaker and New Data Presentations at American Society of Nephrology (ASN) Kidney Week 2024

Biogen Announces Late Breaker and New Data Presentations at American Society of Nephrology (ASN) Kidney Week 2024 Late breaker oral presentation to feature final results of the Phase 2 IGNAZ study...

22 Octubre 2024
UK Regulatory

Biogen Receives U.S. FDA Breakthrough Therapy Designation for Felzartamab for the Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients

Biogen Receives U.S. FDA Breakthrough Therapy Designation for Felzartamab for the Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients Designation is based on data from the...

09 Octubre 2024
UK Regulatory
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
100277.67277.67277.675758277.67DE
400277.67277.67277.677116277.67DE
1200277.67277.67277.674829277.67DE
2600277.67277.67277.674450277.67DE
5200277.67277.67277.673397277.67DE
15600277.67277.67277.675005277.67DE
26000277.67277.67277.674003277.67DE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
SCGLSealand Capital Galaxy Limited
0.54p
(80.00%)
36.26M
OBDOxford Biodynamics Plc
2.11p
(55.15%)
8.3M
MIRIMirriad Advertising Plc
0.18p
(33.33%)
23.04M
CLCOCloudcoco Group Plc
0.26p
(30.00%)
3.42M
IESInvinity Energy Systems Plc
15.00p
(27.66%)
4.57M
ZNTZentra Group Plc
3.50p
(-36.36%)
221.85k
UOGUnited Oil & Gas Plc
0.125p
(-34.21%)
123.45M
SYSSysgroup Plc
21.50p
(-24.56%)
788.98k
ADAAdams Plc
3.50p
(-22.22%)
25k
DSMDowning Strategic Micro-cap Investment Trust Plc
3.70p
(-21.28%)
22.32k
ORCPOracle Power Plc
0.0525p
(-7.89%)
3.65B
NTVONativo Resources Plc
0.0023p
(-8.00%)
1.51B
SYMESupply@me Capital Plc
0.0031p
(-10.14%)
1.11B
KEFIKefi Gold And Copper Plc
0.524p
(-19.63%)
567.23M
ENETEthernity Networks Ltd
0.1425p
(18.75%)
551.92M

Discusión

Ver feed completo
DiscoverGold DiscoverGold 3 minutos hace
$NDX - Striving to follow my Blue-Script, and holding over those two 4Hr EMA's (100 & 200)...
By: Sahara | December 3, 2024

• $NDX - Striving to follow my Blue-Script, and holding over those two 4Hr EMA's (100 & 200)...

pbs.twimg.com/media/Gd4nLYVXUAAgSFJ?f
NDX
Vexari Vexari 3 minutos hace
What is the Mandela Effect

static-3.bitchute.com/live/cover_images/o6UtNZ9JyFvx/j1XTjk68Cq36_320x180.jpg old.bitchute.com/video/j1XTjk68Cq36/ ~~~ How does it interact ~~~
(1:10)

With human subconscious

old.bitchute.com/channel/o6UtNZ9JyFvx/ M
CHILLWILL1704 CHILLWILL1704 3 minutos hace
Just looked into my crystal ball and seen all of us at a big banquet table at Belize with Adjusted at head of the table paying all our expenses--funny to see CoCo on his lap.
MVNT
Prudent Capitalist Prudent Capitalist 4 minutos hace
+17% on well over twice trailing avg. daily volume. NB shares have been very undervalued and were likely hit by some early tax loss selling. But a 17% gain is not that significant when the shares are selling at these depressed levels. Can't get at all excited about $1.56. Long way to go to get b
NB
Lone Clone Lone Clone 4 minutos hace
Kingsmen Identifies Significant New Silver-Gold Drill Target on the Las Coloradas Project

https://www.newsfilecorp.com/release/232150/Kingsmen-Identifies-Significant-New-SilverGold-Drill-Target-on-the-Las-Coloradas-Project

December 03, 2024 8:30 AM EST | Source: Kingsm
RSI38 RSI38 4 minutos hace
You are not kidding Mr.

Hehehehe

RMTD
RMTD
Kaiserwave Kaiserwave 4 minutos hace
Yeah 8 and 9 digit share amounts can get crazy. And look awesome when things get super green.
RDAR
Jahvik Jahvik 4 minutos hace
275 million to go 
Today or tomorrow 4's
HMBL
linkvest linkvest 5 minutos hace
11s are up and printing faster now...... need to get threw all of these air shares and into the 12s for the end of the day.
RDAR
wedman wedman 5 minutos hace
Of course the FDA is corrupt ! It is the deep state ! Most people here probably got the vax ! Not me!
RDGL
NoMoDo NoMoDo 5 minutos hace
Public company hmbl just got a $20 mil asset on their books. $525k worth of debt owed has been forgiven. Some common and preferred shares eliminated as part of effort to clean up balance sheet. Shareholders also own part of private company. 
HMBL
boston745 boston745 5 minutos hace
Deputies rescue pregnant driver who lost control of car
The heart-pounding early-morning rescue on Dec. 2 was caught on dash camera footage shared by the Williamson County Sheriff's Office. Audio from the woman's 911 call was also released.

"I need help. My brakes won't stop. M
TSLA
Kool Aid Man Kool Aid Man 5 minutos hace
Strickland's still owed $103,456 compensation..for doing nothing? This was a burned out 5.5 billion share, .0001 ticker when someone got the bright idea to install a useful idiot bullshitter as THE control person here.

Since SPZI doesn't have enough cash to fund operations without ESC
SPZI
Lime Time Lime Time 6 minutos hace
I doubt the footsie dude will be involved here. My guess is an entire new crew with bright minds and ideas. Sharp wants this to be just like a TSNP but even better.
GVSI
Peace1965 Peace1965 7 minutos hace
This garbage soon will follow INQD ( Delisted )..
INQD
Dallas-Cowboys Dallas-Cowboys 7 minutos hace
I listened to Colette on the UBS conference call nothing new or earth shattering just reinforcing Nvidia's powerhouse position 
UBS
PennyStockTrader2 PennyStockTrader2 7 minutos hace
it is common sense, but we are not a common sense company, its that simple.
MRGE
RickNagra RickNagra 7 minutos hace
Sure wish DT Junior would join our board and send us 160% soaring.  {insert long drawn out sigh}.
FNMA
linkvest linkvest 7 minutos hace
9s are the GOLDEN SHARES to have but the 1s taste just as good when RDAR is sitting at .01......
RDAR
SPANISH_gladiator SPANISH_gladiator 8 minutos hace
whithout falling in delincuency
RMTD
fink fink 8 minutos hace
Don't forget the O/S hasn't changed in a year.

My focus is on buying any dips and Audited. Screw the day to day. The price can go either way for all I care.
IGPK
fink fink 8 minutos hace
Don't forget the O/S hasn't changed in a year.

My focus is on buying any dips and Audited. Screw the day to day. The price can go either way for all I care.
IGPK
FinnMcMissile FinnMcMissile 8 minutos hace
You're usually great at dumbing this stuff down for me....Need a nomo explanation
HMBL
wadegarret wadegarret 8 minutos hace
R59- SMCI

From my understanding SMCI's in house auditors have found nothing wrong with the way SMCI has reported numbers. So now we're all waiting for BDO's formal independent opinion- is that right ? Re, assuming BDO finds nothing wrong, and SMCI makes their $3.75 eps in 2025,
SMCI
Nrdc92 Nrdc92 8 minutos hace
It's not "difficult to understand."  What is difficult to understand is why, if you have a financial stake in success, you tow the company line repeatedly without an ounce of pushback despite the company repeatedly diluting your financial stake, failing to execute, and delivering nothing of value. 
LWLG

Su Consulta Reciente

LSE
0R1B
Biogen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados